Active Cancer Biomarkers Grants

PI Name Organization - Companysort descending Title Major Program / Research Group FOA
Lin, Daniel W. Fred Hutchinson Cancer Research Center Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research PAR-17-233: Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts
Grady, William Mallory Fred Hutchinson Cancer Research Center (PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states. RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Goldman, Radoslav Georgetown University O-glycoproteins in the progression of liver disease PA-18-484: NIH Research Project Grant
Goldman, Radoslav Georgetown University LC-MS Analysis of Site Specific Protein Glycoforms RFA-RM-17-029: Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans
Chung, Fung-Lung Georgetown University gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention PAR-15-307: Translational Studies on Adducts for Cancer Risk Identification and Prevention
Riegel, Anna Tate Georgetown University (PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Mishra, Lopa George Washington University Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer Translational Liver Consortium RFA-CA-17-025: Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01)
Woo, Christina Harvard University Tools to facilitate manipulation of protein-specific glycosylation stoichiometry in cells RFA-RM-18-036: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions
Permuth, Jennifer B H. Lee Moffitt Cancer Ctr & Res Inst Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology PA-18-484: NIH Research Project Grant
Heine, John J H. Lee Moffitt Cancer Ctr & Res Inst Moffitt Imaging Biomarker VAlidation Center Early Detection Research Network, EDRN Clinical Validation Center RFA-CA-14-015: The Early Detection Research Network: Clinical Validation Centers
Hirsch, Fred R Icahn School Of Medicine At Mount Sinai Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Almonte, Maribel International Agency For Res On Cancer Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries RFA-CA-15-001: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)
Wei, Chia-Lin Jackson Laboratory Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Zachara, Natasha Elizabeth Johns Hopkins University Tuning and Tagging the O-GlcNAc Modification RFA-RM-17-030: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions
Brock, Malcolm V Johns Hopkins University Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules PAR-18-310: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed)

Pages